The most recent report that Dupont Capital Management Corp. submitted to the Securities and Exchange Commission indicates that the company recently completed a transaction in which it purchased The Clorox Company (NYSE: CLX). This transaction took place not too long ago. The investment fund shelled out close to 107,000 dollars to purchase 837 shares of stock in the company.
Throughout the past few months, a wide variety of other institutional investors have engaged in transactions that included the buying and selling shares of stock in the company. Federated Hermes Inc. increased the amount of Clorox stock it owns by 86.2% over the second quarter of the fiscal year. Federated Hermes Inc. now holds a total of 1,945,898 shares of the company’s stock, which has a market value of $274,332,000 due to the purchase of 901,040 additional shares during the most recent fiscal period. The percentage of Clorox shares that State Street Corporation owned grew by 9.6 percent over the second quarter. Following the acquisition of an additional 778,269 shares during the most recent quarter, State Street Corp. now owns 8,907,083 shares in the company. The current value of these shares is $1,255,721,000. During the first three months of the year, Invesco Ltd. increased the proportion of Clorox stock held by 38.2 percent. Invesco Ltd. now has 1,051,679 shares in the company following the purchase of an additional 290,833 shares during the most recent quarter. The total value of Invesco Ltd.’s investment in the company equals $146,210,000. During the second quarter, Allspring Global Investments Holdings LLC achieved a 130.6% increase in the proportion of Clorox stock it owned. Allspring Global Investments Holdings LLC now has a total of 449,287 shares of the company’s stock, which are worth a combined total of $63,340,000 after the company acquired an additional 254,476 shares during the preceding quarter. During the second quarter, Sumitomo Mitsui Trust Holdings Inc. increased the amount of Clorox stock owned by 51.3%, making this the last and most important point. The most recent fiscal quarter saw Sumitomo Mitsui Trust Holdings Inc. acquire an additional 242,651 shares of the company’s stock. This brings the total number of shares that it currently possesses in the company to 715,663, with a value of $100,894,000. Institutional investors and hedge funds currently control 79.12% of the company’s shares.
Throughout the most recent few weeks, the shares of CLX have been the focus of commentary from various specialists working in the stock research field. The research note that Deutsche Bank Aktiengesellschaft published on Tuesday, December 6, upgraded Clorox from a “hold” rating to a “buy” rating and raised their target price on the stock from $148,000.00 to $151,000.00. These changes were made in response to recent market activity. According to a report made available to the public on November 2, DA Davidson increased their price target for Clorox’s stock from $125.00 to $155.00 and changed their rating for the company’s stock to “neutral.” Both of these changes were announced in a report. In a research report released on November 2, UBS Group increased the target price for Clorox from $119.00 to $129.00 but still assigned the stock a “sell” rating. JPMorgan Chase & Co. raised their price target for Clorox from $120.00 to $135.00 in a research note released on Friday, January 13. Despite this, the company maintains an “underweight” rating for the stock.
Last but not least, in a research note dated November 2, Morgan Stanley increased their price objective on Clorox from $130.00 to $142,000 while keeping their rating on the stock at “equal weight.” The stock has been given a sell rating by nine research analysts, a recommendation to hold by four experts, and a buy rating by only one of those professionals. The consensus recommendation regarding Clorox’s stock is to “reduce” it, and the average price objective has been established at $136.92, as reported by Bloomberg.
When trading started on Thursday, a share of CLX stock was going for a price of $143.32 per share. In the past year, the share price of The Clorox Company has ranged from $120.50 to $182.89, with a low of $120.50 and a high of $182.89. This stock has a price-to-earnings ratio of 43.96, a price-to-earnings-growth ratio of 3.05, and a beta value of 0.31. The company is currently valued at $17.68 billion on the market. The simple moving average for the stock over the past 50 days is $145.66, and the simple moving average for the past 200 days is $143.20. The current ratio is 0.88, the quick ratio is 0.50, and the debt-to-equity ratio is 4.99. All three ratios are very close to each other. There is a striking similarity between each of the three ratios.
On November 1, the most recent quarterly earnings report for Clorox, traded on the NYSE under the symbol CLX, was made public. The company announced earnings per share of $0.93 for the quarter, which was $0.20 higher than the estimate from industry analysts, who had predicted earnings per share of $0.73. Despite having a net margin of only 5.75 percent, Clorox could generate a return on equity of 83,000%. The revenue for the quarter came in at $1.74 billion, which was significantly higher than the analysts’ average estimate of $1.69 billion for the amount of revenue generated during the quarter. Professionals in the field of equity research forecast that The Clorox Company will make a profit of $4.11 per share during the current fiscal year.
In addition, the company disclosed that it would be implementing a quarterly dividend, which is scheduled to be paid out on February 10. On January 25, 2019, dividends for $1.18 per share will be distributed to shareholders of record as of the previous day. This translates to a yield of 3.29% and a dividend payment of $4.72 yearly for every shareholder. On Tuesday, January 24, the date in question, this dividend will be considered to have been paid out in its entirety. Clorox’s dividend payout ratio (also known as DPR) currently stands at 144.79%.
The Clorox Company is a manufacturer that serves wholesale and retail clients by providing their customers with their products. It expands its coverage to include the commercial spheres of international business, household business, lifestyle business, and health and wellness business. The United States of America plays a significant role in marketing and selling products classified as belonging to the “Health and Wellness” category. Products such as cleaning supplies, items for professionals, vitamins, minerals, and dietary supplements are included in this category.
Discussion about this post